Marble Harbor Investment Counsel LLC reduced its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 0.3% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 248,748 shares of the pharmacy operator’s stock after selling 700 shares during the period. Walgreens Boots Alliance comprises about 3.2% of Marble Harbor Investment Counsel LLC’s investment portfolio, making the stock its 7th biggest position. Marble Harbor Investment Counsel LLC’s holdings in Walgreens Boots Alliance were worth $18,134,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the company. Sei Investments Co. boosted its position in Walgreens Boots Alliance by 100.9% in the second quarter. Sei Investments Co. now owns 349,451 shares of the pharmacy operator’s stock valued at $20,970,000 after buying an additional 175,551 shares in the last quarter. California Public Employees Retirement System lifted its position in shares of Walgreens Boots Alliance by 7.7% during the second quarter. California Public Employees Retirement System now owns 2,303,917 shares of the pharmacy operator’s stock worth $138,270,000 after purchasing an additional 165,048 shares in the last quarter. Bridgewater Associates LP lifted its position in shares of Walgreens Boots Alliance by 109.1% during the second quarter. Bridgewater Associates LP now owns 657,649 shares of the pharmacy operator’s stock worth $39,469,000 after purchasing an additional 343,062 shares in the last quarter. We Are One Seven LLC acquired a new position in shares of Walgreens Boots Alliance during the third quarter worth approximately $1,295,000. Finally, Schaller Investment Group Inc. acquired a new position in shares of Walgreens Boots Alliance during the second quarter worth approximately $9,152,000. Institutional investors and hedge funds own 64.57% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total transaction of $217,457.28. Following the completion of the sale, the director now directly owns 8,207 shares of the company’s stock, valued at $652,292.36. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the sale, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 66,706 shares of company stock valued at $5,268,584. 14.80% of the stock is currently owned by insiders.

WBA opened at $82.39 on Friday. The company has a quick ratio of 0.38, a current ratio of 0.82 and a debt-to-equity ratio of 0.47. The company has a market cap of $77.75 billion, a P/E ratio of 13.61, a price-to-earnings-growth ratio of 1.30 and a beta of 0.74. Walgreens Boots Alliance Inc has a fifty-two week low of $59.07 and a fifty-two week high of $83.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.45 by $0.03. The business had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. Walgreens Boots Alliance had a net margin of 3.82% and a return on equity of 21.75%. On average, equities research analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Investors of record on Monday, November 12th will be paid a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.14%. The ex-dividend date is Thursday, November 8th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.

A number of equities analysts have recently issued reports on the stock. ValuEngine upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, September 21st. TheStreet upgraded shares of Walgreens Boots Alliance from a “c+” rating to a “b” rating in a research report on Wednesday, September 12th. BidaskClub upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, August 21st. Cowen lowered shares of Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 target price on the stock. in a research report on Monday, July 23rd. Finally, Pivotal Research upped their target price on shares of Walgreens Boots Alliance from $60.00 to $72.00 and gave the stock a “hold” rating in a research report on Monday, October 15th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the stock. Walgreens Boots Alliance has an average rating of “Hold” and a consensus price target of $78.22.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2018/11/10/marble-harbor-investment-counsel-llc-sells-700-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

See Also: What is a stock split?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.